Avoro Capital Advisors’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,250,000
| Closed | -$19.6M | – | 37 |
|
|
2024
Q4 | $19.6M | Sell |
2,250,000
-1,291,505
| -36% | -$11.2M | 0.28% | 36 |
|
|
2024
Q3 | $69.2M | Hold |
3,541,505
| – | – | 1.01% | 22 |
|
|
2024
Q2 | $72.9M | Sell |
3,541,505
-308,495
| -8% | -$6.35M | 0.97% | 25 |
|
|
2024
Q1 | $82.1M | Buy |
3,850,000
+870,000
| +29% | +$18.6M | 0.96% | 24 |
|
|
2023
Q4 | $42.9M | Hold |
2,980,000
| – | – | 0.59% | 24 |
|
|
2023
Q3 | $27.2M | Sell |
2,980,000
-125,000
| -4% | -$1.14M | 0.42% | 27 |
|
|
2023
Q2 | $32.9M | Hold |
3,105,000
| – | – | 0.45% | 28 |
|
|
2023
Q1 | $38M | Hold |
3,105,000
| – | – | 0.56% | 24 |
|
|
2022
Q4 | $38.5M | Sell |
3,105,000
-420,000
| -12% | -$5.21M | 0.58% | 26 |
|
|
2022
Q3 | $48.2M | Sell |
3,525,000
-1,275,000
| -27% | -$17.4M | 0.89% | 20 |
|
|
2022
Q2 | $88M | Hold |
4,800,000
| – | – | 1.74% | 15 |
|
|
2022
Q1 | $77.2M | Buy |
4,800,000
+800,000
| +20% | +$12.9M | 1.41% | 17 |
|
|
2021
Q4 | $56M | Hold |
4,000,000
| – | – | 0.95% | 18 |
|
|
2021
Q3 | $74.9M | Sell |
4,000,000
-140,000
| -3% | -$2.62M | 1.18% | 19 |
|
|
2021
Q2 | $86.3M | Buy |
4,140,000
+140,000
| +4% | +$2.92M | 1.5% | 17 |
|
|
2021
Q1 | $113M | Hold |
4,000,000
| – | – | 1.95% | 14 |
|
|
2020
Q4 | $131M | Buy |
4,000,000
+1,565,000
| +64% | +$51.1M | 2.25% | 14 |
|
|
2020
Q3 | $74.6M | Buy |
2,435,000
+1,385,000
| +132% | +$42.4M | 1.06% | 21 |
|
|
2020
Q2 | $17.1M | Buy |
+1,050,000
| New | +$17.1M | 0.34% | 35 |
|